November 27, 2012 – Boonton, NJ and Cambridge, MA – Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarix Pharmaceuticals today announced that the companies have entered into a definitive licensing ...
Tarix Pharmaceuticals will develop an oral formulation of its lead peptide drug candidate TXA127 using Unigene’s Peptelligence™ technology platform, as the companies extended a feasibility partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback